79 related articles for article (PubMed ID: 9422268)
41. [Who can be dismissed in rectal cancer management?].
Rouanet P
Cancer Radiother; 2017 Oct; 21(6-7):536-538. PubMed ID: 28864048
[TBL] [Abstract][Full Text] [Related]
42. Combined-treatment approaches in the management of rectal cancer.
Gunderson LL
Recent Results Cancer Res; 1988; 110():119-29. PubMed ID: 3043587
[No Abstract] [Full Text] [Related]
43. [Cancer of the rectum. Epidemiology, pathological anatomy, diagnosis, clinical course, management and prevention].
Adloff M
Rev Prat; 1995 Dec; 45(19):2493-9. PubMed ID: 8571065
[No Abstract] [Full Text] [Related]
44. A colorectal surgeon's perspective on the current surgical options for rectal cancer after chemoradiation.
Stahl TJ
Oncology (Williston Park); 2013 Oct; 27(10):968, 970-1. PubMed ID: 24367852
[No Abstract] [Full Text] [Related]
45. Rectal cancer: Current issues.
Kavolius JP; LoRe E
Curr Surg; 2002; 59(1):32-41. PubMed ID: 16093102
[No Abstract] [Full Text] [Related]
46. Evolving Strategy for Surgical Management of Oral Cancer: Present and Future.
Joo YH; Koo BS
Clin Exp Otorhinolaryngol; 2019 May; 12(2):101-102. PubMed ID: 30942046
[No Abstract] [Full Text] [Related]
47. TP53 genotype but not p53 immunohistochemical result predicts response to preoperative short-term radiotherapy in rectal cancer.
Kandioler D; Zwrtek R; Ludwig C; Janschek E; Ploner M; Hofbauer F; Kührer I; Kappel S; Wrba F; Horvath M; Karner J; Renner K; Bergmann M; Karner-Hanusch J; Pötter R; Jakesz R; Teleky B; Herbst F
Ann Surg; 2002 Apr; 235(4):493-8. PubMed ID: 11923604
[TBL] [Abstract][Full Text] [Related]
48. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
49. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
50. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
[TBL] [Abstract][Full Text] [Related]
51. Sphincter preservation therapy for rectal cancer.
Aitken C; Breen E; Mamon HJ
Clin Adv Hematol Oncol; 2003 Dec; 1(12):735-40. PubMed ID: 16258478
[TBL] [Abstract][Full Text] [Related]
52. Management of rectal cancer: short- vs. long-course preoperative radiation.
Mohiuddin M; Marks J; Marks G
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):636-43. PubMed ID: 19014778
[TBL] [Abstract][Full Text] [Related]
53. Critical issues in the evolving management of rectal cancer.
Mohiuddin M; Ahmed MM
Semin Oncol; 1997 Dec; 24(6):732-44. PubMed ID: 9422268
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
